Welcome to the PICKED Project, an EU-funded initiative dedicated to transforming the management of chronic kidney disease (CKD) through personalized medicine. With a consortium of 10 associated partners across Europe, PICKED trains the next generation of scientists to innovate in early detection, patient stratification, and individualized treatment approaches. Through cutting-edge research in biomarkers, bioinformatics, and quality of life assessment, PICKED is paving the way for tailored healthcare solutions that can make a meaningful impact on the lives of CKD patients.
Chronic kidney disease (CKD) is a significant global health concern affecting over 850 million people. It often progresses silently, impacting patients’ lives and increasing the burden on healthcare systems. Despite its prevalence, awareness remains low, and many unmet needs persist in CKD care. The PICKED Project addresses these gaps by focusing on innovative research and targeted therapies that can better serve CKD patients.
Personalized medicine has the potential to tailor interventions based on individual patient characteristics, creating more effective treatments and better outcomes. PICKED’s approach focuses on using biomarkers, bioinformatics, and ethical assessments to meet this need, advancing healthcare beyond traditional, one-size-fits-all approaches.
PICKED brings together experts from diverse fields, including nephrology, proteomics, ethics, and bioinformatics. This unique collaboration allows us to tackle CKD’s complexities from multiple angles, paving the way for more nuanced and effective solutions.
©Copyright. All rights reserved.
Wir benötigen Ihre Zustimmung zum Laden der Übersetzungen
Wir nutzen einen Drittanbieter-Service, um den Inhalt der Website zu übersetzen, der möglicherweise Daten über Ihre Aktivitäten sammelt. Bitte überprüfen Sie die Details in der Datenschutzerklärung und akzeptieren Sie den Dienst, um die Übersetzungen zu sehen.